Tokyo Tape
Sign in
← Ono Pharmaceutical

Quarterly report · Q3

4528.TEDINET S100SO43
Period2023-04-01 → 2023-12-31
Filed2024-02-06
StandardIFRS
ConsolidatedYes
Data checks16 of 16 passed
Key figures · 61
MetricValuePeriodScopeSource row
Revenue¥389.9bn2023-04-01 → 2023-12-31Cons.Revenue IFRS
Revenue¥131.2bn2023-10-01 → 2023-12-31dCons.Revenue IFRS
Revenue¥447.2bn2022-04-01 → 2023-03-31Cons.Revenue IFRS (5-year summary)
Revenue¥339.0bn2022-04-01 → 2022-12-31Cons.Revenue IFRS
Revenue¥122.3bn2022-10-01 → 2022-12-31dCons.Revenue IFRS
Operating income¥144.6bn2023-04-01 → 2023-12-31Cons.Operating profit loss IFRS
Operating income¥47.6bn2023-10-01 → 2023-12-31dCons.Operating profit loss IFRS
Operating income¥122.6bn2022-04-01 → 2022-12-31Cons.Operating profit loss IFRS
Operating income¥42.3bn2022-10-01 → 2022-12-31dCons.Operating profit loss IFRS
Profit before tax¥147.3bn2023-04-01 → 2023-12-31Cons.Profit loss before tax IFRS
Profit before tax¥48.0bn2023-10-01 → 2023-12-31dCons.Profit loss before tax IFRS
Profit before tax¥143.5bn2022-04-01 → 2023-03-31Cons.Profit loss before tax IFRS (5-year summary)
Profit before tax¥124.4bn2022-04-01 → 2022-12-31Cons.Profit loss before tax IFRS
Profit before tax¥43.4bn2022-10-01 → 2022-12-31dCons.Profit loss before tax IFRS
Net income (owners)¥110.5bn2023-04-01 → 2023-12-31Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥36.1bn2023-10-01 → 2023-12-31dCons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥112.7bn2022-04-01 → 2023-03-31Cons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income (owners)¥95.7bn2022-04-01 → 2022-12-31Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥33.3bn2022-10-01 → 2022-12-31dCons.Profit loss attributable to owners of parent IFRS
Net income¥110.6bn2023-04-01 → 2023-12-31Cons.Profit loss IFRS
Net income¥36.1bn2023-10-01 → 2023-12-31dCons.Profit loss IFRS
Net income¥95.8bn2022-04-01 → 2022-12-31Cons.Profit loss IFRS
Net income¥33.4bn2022-10-01 → 2022-12-31dCons.Profit loss IFRS
Total assets¥891.7bnat 2023-12-31Cons.Assets IFRS
Total assets¥882.4bnat 2023-03-31Cons.Assets IFRS
Total assets¥830.5bnat 2022-12-31Cons.Total assets IFRS (5-year summary)
Total liabilities¥101.0bnat 2023-12-31Cons.Liabilities IFRS
Total liabilities¥134.6bnat 2023-03-31Cons.Liabilities IFRS
Net assets / equity¥790.7bnat 2023-12-31Cons.Equity IFRS
Net assets / equity¥747.8bnat 2023-03-31Cons.Equity IFRS
Net assets / equity¥727.3bnat 2022-12-31Cons.Equity IFRS
Net assets / equity¥661.7bnat 2022-03-31dCons.Equity IFRS
Equity (owners)¥784.7bnat 2023-12-31Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥741.9bnat 2023-03-31Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥721.4bnat 2022-12-31Cons.Equity attributable to owners of parent IFRS (5-year summary)
Cash & equivalents¥102.2bnat 2023-12-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥96.1bnat 2023-03-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥108.6bnat 2022-12-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥69.1bnat 2022-03-31dCons.Cash and cash equivalents IFRS
Operating cash flow¥61.5bn2023-04-01 → 2023-12-31Cons.Net cash provided by used in operating activities IFRS
Operating cash flow¥159.6bn2022-04-01 → 2023-03-31Cons.Cash flows from used in operating activities IFRS (5-year summary)
Operating cash flow¥115.1bn2022-04-01 → 2022-12-31Cons.Net cash provided by used in operating activities IFRS
Investing cash flow¥19.4bn2023-04-01 → 2023-12-31Cons.Net cash provided by used in investing activities IFRS
Investing cash flow−¥100.3bn2022-04-01 → 2023-03-31Cons.Cash flows from used in investing activities IFRS (5-year summary)
Investing cash flow−¥44.9bn2022-04-01 → 2022-12-31Cons.Net cash provided by used in investing activities IFRS
Financing cash flow−¥75.4bn2023-04-01 → 2023-12-31Cons.Net cash provided by used in financing activities IFRS
Financing cash flow−¥32.5bn2022-04-01 → 2023-03-31Cons.Cash flows from used in financing activities IFRS (5-year summary)
Financing cash flow−¥30.9bn2022-04-01 → 2022-12-31Cons.Net cash provided by used in financing activities IFRS
EPS (basic)¥229.082023-04-01 → 2023-12-31Cons.Basic earnings loss per share IFRS
EPS (basic)¥75.772023-10-01 → 2023-12-31dCons.Basic earnings loss per share IFRS
EPS (basic)¥230.852022-04-01 → 2023-03-31Cons.Basic earnings loss per share IFRS (5-year summary)
EPS (basic)¥195.92022-04-01 → 2022-12-31Cons.Basic earnings loss per share IFRS
EPS (basic)¥68.232022-10-01 → 2022-12-31dCons.Basic earnings loss per share IFRS
EPS (diluted)¥229.062023-04-01 → 2023-12-31Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥75.762023-10-01 → 2023-12-31dCons.Diluted earnings loss per share IFRS
EPS (diluted)¥230.792022-04-01 → 2023-03-31Cons.Diluted earnings loss per share IFRS (5-year summary)
EPS (diluted)¥195.882022-04-01 → 2022-12-31Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥68.222022-10-01 → 2022-12-31dCons.Diluted earnings loss per share IFRS
Equity ratio88.0%at 2023-12-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio84.1%at 2023-03-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio86.9%at 2022-12-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

All source rows · 573
ItemContextValueUnit
Research and development expenditure recognized as expense during period IFRSCurrentQuarterDuration27132000000JPY
Other income IFRSPrior1QuarterDuration61000000JPY
Other income IFRSCurrentQuarterDuration85000000JPY
Other expenses IFRSPrior1QuarterDuration438000000JPY
Other expenses IFRSCurrentQuarterDuration165000000JPY
Operating profit loss IFRSPrior1QuarterDuration42320000000JPY
Operating profit loss IFRSCurrentQuarterDuration47590000000JPY
Finance income IFRSPrior1QuarterDuration1185000000JPY
Finance income IFRSCurrentQuarterDuration1512000000JPY
Finance costs IFRSPrior1QuarterDuration145000000JPY
Finance costs IFRSCurrentQuarterDuration1106000000JPY
Share of profit loss of investments accounted for using equity method IFRSPrior1QuarterDuration1000000JPY
Share of profit loss of investments accounted for using equity method IFRSCurrentQuarterDuration0JPY
Profit loss before tax IFRSPrior1QuarterDuration43360000000JPY
Profit loss before tax IFRSCurrentQuarterDuration47996000000JPY
Income tax expense IFRSPrior1QuarterDuration9975000000JPY
Income tax expense IFRSCurrentQuarterDuration11906000000JPY
Profit loss IFRSPrior1QuarterDuration33385000000JPY
Profit loss IFRSCurrentQuarterDuration36090000000JPY
Profit loss attributable to owners of parent IFRSPrior1QuarterDuration33317000000JPY
Profit loss attributable to owners of parent IFRSCurrentQuarterDuration36052000000JPY
Profit loss attributable to non controlling interests IFRSPrior1QuarterDuration68000000JPY
Profit loss attributable to non controlling interests IFRSCurrentQuarterDuration37000000JPY
Profit loss IFRSPrior1QuarterDuration33385000000JPY
Profit loss IFRSCurrentQuarterDuration36090000000JPY
Basic earnings loss per share IFRSPrior1QuarterDuration68.23
Basic earnings loss per share IFRSCurrentQuarterDuration75.77
Diluted earnings loss per share IFRSPrior1QuarterDuration68.22
Diluted earnings loss per share IFRSCurrentQuarterDuration75.76
Profit loss IFRSPrior1YTDDuration95827000000JPY
Profit loss IFRSCurrentYTDDuration110610000000JPY
Net change in fair value of equity instruments designated as measured at fair value through other comprehensive income net of tax items that will not be reclassified to profit or loss oci IFRSPrior1YTDDuration-743000000JPY
Net change in fair value of equity instruments designated as measured at fair value through other comprehensive income net of tax items that will not be reclassified to profit or loss oci IFRSCurrentYTDDuration6728000000JPY
Remeasurements of defined benefit plans net of tax items that will not be reclassified to profit or loss oci IFRSPrior1YTDDuration-41000000JPY
Remeasurements of defined benefit plans net of tax items that will not be reclassified to profit or loss oci IFRSCurrentYTDDuration-79000000JPY
Share of net changes in the fair value of financial assets measured through other comprehensive income of entities accounted for using equity method net of tax items that will not be reclassified to profit or loss oci IFRSPrior1YTDDuration3000000JPY
Share of net changes in the fair value of financial assets measured through other comprehensive income of entities accounted for using equity method net of tax items that will not be reclassified to profit or loss oci IFRSCurrentYTDDuration-4000000JPY
Total of items that will not be reclassified to profit or loss oci IFRSPrior1YTDDuration-781000000JPY
Total of items that will not be reclassified to profit or loss oci IFRSCurrentYTDDuration6645000000JPY
Exchange differences on translation of foreign operations net of tax items that may be reclassified to profit or loss oci IFRSPrior1YTDDuration377000000JPY
Exchange differences on translation of foreign operations net of tax items that may be reclassified to profit or loss oci IFRSCurrentYTDDuration1000000000JPY
Effective portion of cash flow hedges net of tax items that may be reclassified to profit or loss oci IFRSPrior1YTDDuration-127000000JPY
Effective portion of cash flow hedges net of tax items that may be reclassified to profit or loss oci IFRSCurrentYTDDuration-1038000000JPY
Total of items that may be reclassified to profit or loss oci IFRSPrior1YTDDuration250000000JPY
Total of items that may be reclassified to profit or loss oci IFRSCurrentYTDDuration-38000000JPY
Other comprehensive income IFRSPrior1YTDDuration-530000000JPY
Other comprehensive income IFRSCurrentYTDDuration6608000000JPY
Comprehensive income IFRSPrior1YTDDuration95297000000JPY
Comprehensive income IFRSCurrentYTDDuration117218000000JPY
Comprehensive income attributable to owners of parent IFRSPrior1YTDDuration95137000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 16 of 16 passed
balance sheet identityconsolidated 2023-03-31pass
balance sheet identityconsolidated 2023-12-31pass
dei present pass
period resolution pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-12-31pass
statement vs summary · net income attributable to parentconsolidated 2022-10-01/2022-12-31pass
statement vs summary · net income attributable to parentconsolidated 2023-04-01/2023-12-31pass
statement vs summary · net income attributable to parentconsolidated 2023-10-01/2023-12-31pass
statement vs summary · operating cash flowconsolidated 2022-04-01/2022-12-31pass
statement vs summary · operating cash flowconsolidated 2023-04-01/2023-12-31pass
statement vs summary · revenueconsolidated 2022-04-01/2022-12-31pass
statement vs summary · revenueconsolidated 2022-10-01/2022-12-31pass
statement vs summary · revenueconsolidated 2023-04-01/2023-12-31pass
statement vs summary · revenueconsolidated 2023-10-01/2023-12-31pass
statement vs summary · total assetsconsolidated 2023-03-31pass
statement vs summary · total assetsconsolidated 2023-12-31pass